BioSpace News Archive

Altan Pharma Limited (“Altan”), an Irish specialty pharmaceutical company, today announced that the United States Patent and Trademark Office (“USPTO”) has granted two patents to Altan covering its intravenous formulation of acetaminophen (paracetamol).

University of Nevada, Reno School of Medicine researcher finds new molecular link between type 2 diabetes and obesity that may lead to targeted drug treatments

CEO “extremely encouraged by the results from our ongoing Phase 1 trial of AB928.”

Company will showcase full suite of rehabilitation and pain management technologies in booth #1835

Two platform presentations and 19 posters explore the potential of fremanezumab as an investigational treatment option for the prevention of migraine COPAXONE® (glatiramer acetate injection) and AUSTEDO® (deutetrabenazine) tablets data highlight Teva’s ongoing clinical research

Data show ability of destabilizing domain technology platform to regulate expression of secreted and membrane-bound proteins in cell therapies

DaVita Inc. (NYSE: DVA), a leading provider of kidney care services in the United States and in 11 countries around the world, announced today that it will hold its quarterly conference call to discuss first quarter results on Thursday, May 3, 2018, at 5:00 p.m. Eastern Time.

Data from TOUR™ Observational Patient Registry Highlights Positive Clinical Response Rates in Elderly and Obese Patients Additional VIBATIV Study Results Demonstrate Greater in vitro Potency than Competitor Antibiotics Against Difficult-to-Treat Staphylococcus aureus Pathogens including Challenging Multidrug Resistant (MDR) MRSA Isolates

Fresh capital will support growth in robotics and software teams

CBT Pharmaceuticals (CBT), a U.S. and China-based innovative biopharmaceutical company committed to becoming a leader in the discovery and development of oncology combination therapies, presented preclinical in-vivo data and animal safety pharmacology studies of CBT-102